Cancer cells must frequently deal with remnants of replication problems from the preceding S-phase, either because of oncogene-driven cell cycles, or as a result of defective HR pathways due to the loss of tumor suppressor genes such as BRCA1 and BRCA2. The gene discussed is BRCA2; the disease is cancer.